Well, yesterdays Daily Feature had the winner top rated and won @ $11 wth the fav 2nd rated but my suggestion it was not a great race anyway and also using the track recommendations none of yesterdays meeting were part of the track selection anyway. In spite of that HR2D has a massive profit as did Winform top two. Goes to show. While we piked out tracks where the various programs were at their best it doesn’t mean they never win elsewhere. The same things apply e.g. top rated winform horses yesterday that were favourite won a handy profit, as they normally do. Five meetings today and all bettable with no wet tracks although Belmont is expected soft 5. Have fun. Yesterday I had a 15 minute one on one with the CEO of Auscann , who made a presentation at the Radisson Blue in Sydney yesterday. She spoke about the problems the company was having was getting doctors to actallu prescribe the medical Cannabis medications simply because although it is ll approved, doctors aren’t trained in dosage and so on and the correct method as some are oils and there are droppesr and so on so part of what Auscann is doing is sending teams out to train doctors about the products which are common in overseas markets like Canada where over 260,000 people are prescribed each year. They are actually patenting a dosage system which they can export world wide once in place so that by mid 2019 it will be all systems go. In the meantime, the share prices of medical cannabis companies , Cann group is the other big one, are wandering all over the place. My own super fund is heavily invested in what is the future of pain medication as it has few side effects compared to Endone and Forts which are liable to make people dependent. Another company presenting at this seminar makes more money out of selling treatments for painkiller addiction than for the drugs themselves in the first place, all of which are poppy based or opiates. Enjoy the punt today.